October 09, 2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

Got a startup idea? Curious about entrepreneurship? Then the GeneNovate program is the perfect place to start!

Objective

GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine. The program targets early-career scientists and physicians, such as advanced students, PhD candidates, and Postdocs, but it is also open to experienced researchers and medical professionals.

The GeneNovate program runs from December 2025 to June 2026 and includes a kick-off meeting in December, six theoretical input sessions (hybrid), six full-day workshops (onsite), team-based preparation and presentation of startup pitches and culminates in the Final Event in Munich

A key strength of the program lies in its collaborative approach, connecting participants across all GeneNovate locations in Germany. 

This comprehensive program is offered free of charge

Locations hosting the GeneNovate Workshops:

  • Berlin
  • Heidelberg
  • Munich
  • Region EAST (Dresden, Leipzig)
  • Region NORTH (Braunschweig, Göttingen, Hannover, …)
  • Region NRW 1 (Aachen, Bonn, Cologne, Düsseldorf, …)
  • Region NRW 2 (Bochum, Dortmund, Duisburg, Essen, …)
  • Region RHINE-MAIN (Mainz, …)
  • Region SOUTHWEST (Freiburg, Tübingen)

Apply now!

Registration for the remaining locations will open at a later date

Participate in Berlin: Submit your application here

Participate in Heidelberg: Submit your application here

Participate in Munich: Submit your application here

Participate in Region EAST (Dresden, Leipzig): Submit your application here

Participate in Region RHINE-MAIN (Mainz, …): Submit your application here


Program Framework

Kick-off Meeting | December 2025 

  • Participants will form teams and will be matched with mentors
  • Networking opportunity
  • Duration approx. 4 hours
  • Onsite participation at your selected location 

Theoretical Input Sessions | January 2026 to June 2026 

  • 6 theory sessions, held once per month, each lasting 4 hours
  • Onsite participation in Freiburg and Cologne, live stream for all other locations 

Workshops | January 2026 to June 2026 

  • Participants work in group exercises on the practical application of insights from the theoretical input sessions
  • Training from experts and experiences startups
  • 6 interactive sessions, held once per month, each lasting 6–8 hours
  • Onsite participation at your selected location 

Coaching Sessions with Mentors | January 2026 to June 2026 

  • Teams meet their mentor for about 1 hour after each workshop (in person or virtual) to prepare and rehearse the pitch for their startup
  • Approx. 8 hours in total 

Pre-selection of teams for the Final Event | June 2026 

  • Every team pitches their startup in front of a selection committee
  • Teams with the strongest pitches are selected to present at the Final Event in Munich 

Final Event 2026 in Munich | June 2026 

  • All participants, alumni, experts and mentors from all GeneNovate locations come together for networking, including the possibility to approach investors
  • Selected teams pitch their startup in front of investors
  • Panel discussions of experts and investors in the field
  • 1 full day in Munich

Our latest News

discover more
AbbVie US + EU Golden Ticket 2025 – Apply by November 7, 2025

AbbVie US + EU Golden Ticket 2025 – Apply by November 7, 2025

AbbVie is launching a US and Europe based golden ticket. The award consists of one golden ticket, which provides one year of fully paid individual bench, a desk and membership at one of BioLabs’ operating locations in the US, France or Germany. The award is intended for early-stage biotech companies developing therapeutics (not devices) in […]

Two Life Sciences Bridge Awards for Heidelberg researchers

Two Life Sciences Bridge Awards for Heidelberg researchers

Double success for Heidelberg life sciences: Two of the three prestigious Life Sciences Bridge Awards presented this year go to Heidelberg University’s Medical Faculty. The Aventis Foundation honors infectious disease specialist Dr. Frauke Mücksch and neurologist Dr. Varun Venkataramani for their groundbreaking research. While Mücksch is searching for new ways to one day cure HIV […]

How Fibrosis Disrupts the Heart’s Electrical Signals

How Fibrosis Disrupts the Heart’s Electrical Signals

Innovative imaging technique reveals hidden electrical connections in diseased hearts and provides new therapeutic approaches Cardiac fibrosis can be life-threatening: the formation of connective tissue in the heart muscle causes it to become stiffer, impairs electrical signal transmission, and weakens pumping capacity, which can lead to cardiac arrhythmias. However, the effects of cardiac fibrosis on […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp